A Web-Based Survey on Factors for Unvaccination and Adverse Reactions of SARS-CoV-2 Vaccines in Chinese Patients with Psoriasis

References

• Tan L, Zhao S, Zhu W, et al. The Akkermansia muciniphila is a gut microbiota signature in psoriasis. Exp Dermatol. 2018;27(2):144–149. doi:10.1111/exd.13463
   PubMed Web of Science ®Google Scholar
• Zeng C, Wen B, Hou G, et al. Lipidomics profiling reveals the role of glycerophospholipid metabolism in psoriasis. Gigascience. 2017;6(10):1–11. doi:10.1093/gigascience/gix087
   Web of Science ®Google Scholar
• Rahier JF, Moutschen M, Van Gompel A, et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford). 2010;49(10):1815–1827. doi:10.1093/rheumatology/keq183
   PubMed Web of Science ®Google Scholar
• Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J. Psoriasis. Lancet. 2021;397(10281):1301–1315. doi:10.1016/S0140-6736(20)32549-6
   PubMed Web of Science ®Google Scholar
• Wang J, Jing R, Lai X, et al. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines (Basel). 2020;8(3):482.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Luo X, Ma ZF. Willingness of the general population to accept and pay for COVID-19 vaccination during the early stages of COVID-19 pandemic: a nationally representative survey in mainland China. Hum Vaccin Immunother. 2021;17(6):1622–1627. doi:10.1080/21645515.2020.1847585
   PubMed Web of Science ®Google Scholar
• Wack S, Patton T, Ferris LK. COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: review of available evidence. J Am Acad Dermatol. 2021;85(5):1274–1284. doi:10.1016/j.jaad.2021.07.054
   PubMed Web of Science ®Google Scholar
• Krajewski PK, Matusiak L, Szepietowski JC. Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine. J Eur Acad Dermatol Venereol. 2021. doi:10.1111/jdv.17449
   Web of Science ®Google Scholar
• Onsun N, Kaya G, Isik BG, Gunes B. A generalized pustular psoriasis flare after CoronaVac COVID-19 vaccination: case report. Health Promot Perspect. 2021;11(2):261–262. doi:10.34172/hpp.2021.32
   PubMed Web of Science ®Google Scholar
• Wang Q, Luo Y, Lv C, et al. Nonadherence to treatment and patient-reported outcomes of psoriasis during the COVID-19 epidemic: a web-based survey. Patient Prefer Adherence. 2020;14:1403–1409. doi:10.2147/PPA.S263843
   PubMed Web of Science ®Google Scholar
• Kuang Y, Shen M, Wang Q, et al. Association of outdoor activity restriction and income loss with patient-reported outcomes of psoriasis during the COVID-19 pandemic: a web-based survey. J Am Acad Dermatol. 2020;83(2):670–672. doi:10.1016/j.jaad.2020.05.018
   PubMed Web of Science ®Google Scholar
• Liu ZW, Yu Y, Hu M, Liu HM, Zhou L, Xiao SY. PHQ-9 and PHQ-2 for screening depression in Chinese rural elderly. PLoS One. 2016;11(3):e0151042. doi:10.1371/journal.pone.0151042
   PubMed Web of Science ®Google Scholar
• Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016;39:24–31. doi:10.1016/j.genhosppsych.2015.11.005
   PubMed Web of Science ®Google Scholar
• Dutheil F, Pereira B, Moustafa F, Naughton G, Lesage FX, Lambert C. At-risk and intervention thresholds of occupational stress using a visual analogue scale. PLoS One. 2017;12(6):e0178948. doi:10.1371/journal.pone.0178948
   PubMed Web of Science ®Google Scholar
• Lesage FX, Berjot S. Validity of occupational stress assessment using a visual analogue scale. Occup Med (Lond). 2011;61(6):434–436. doi:10.1093/occmed/kqr037
   PubMed Web of Science ®Google Scholar
• Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49(12):1373–1379. doi:10.1016/S0895-4356(96)00236-3
   PubMed Web of Science ®Google Scholar
• Sotiriou E, Bakirtzi K, Papadimitriou I, et al. COVID-19 vaccination intention among patients with psoriasis compared with immunosuppressed patients with other skin diseases and factors influencing their decision. Br J Dermatol. 2021;185(1):209–210. doi:10.1111/bjd.19882
   PubMed Web of Science ®Google Scholar
• Xia S, Zhang Y, Wang Y, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial. Lancet Infect Dis. 2021;21(1):39–51. doi:10.1016/S1473-3099(20)30831-8
   PubMed Web of Science ®Google Scholar
• Tanriover MD, Doganay HL, Akova M, et al. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey. Lancet. 2021;398(10296):213–222. doi:10.1016/S0140-6736(21)01429-X
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zeng G, Pan H, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(2):181–192. doi:10.1016/S1473-3099(20)30843-4
   PubMed Web of Science ®Google Scholar
• Yang S, Li Y, Dai L, et al. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Lancet Infect Dis. 2021;21(8):1107–1119. doi:10.1016/S1473-3099(21)00127-4
   PubMed Web of Science ®Google Scholar
• Sprute R, Schumacher S, Pauls M, Pauls W, Cornely OA. Delayed cutaneous hypersensitivity reaction to vaxzevria (ChAdOx1-S) vaccine against SARS-CoV-2. Drugs R D. 2021. doi:10.1007/s40268-021-00358-z
   PubMed Web of Science ®Google Scholar
• Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–416. doi:10.1056/NEJMoa2035389
   PubMed Web of Science ®Google Scholar
• Skroza N, Bernardini N, Tolino E, et al. Safety and impact of anti-COVID-19 vaccines in psoriatic patients treated with biologics: a real life experience. J Clin Med. 2021;10(15):3355. doi:10.3390/jcm10153355
   PubMed Web of Science ®Google Scholar
• Diotallevi F, Campanati A, Radi G, et al. Vaccination against SARS-CoV-2 and psoriasis: the three things every dermatologist should know. J Eur Acad Dermatol Venereol. 2021;35(7):e428–e30. doi:10.1111/jdv.17256
   PubMed Web of Science ®Google Scholar
• Lehmann M, Schorno P, Hunger RE, Heidemeyer K, Feldmeyer L, Yawalkar N. New onset of mainly guttate psoriasis after COVID-19 vaccination: a case report. J Eur Acad Dermatol Venereol. 2021;35(11). doi:10.1111/jdv.17561
   Web of Science ®Google Scholar
• Nagrani P, Jindal R, Goyal D. Onset/flare of psoriasis following the ChAdOx1 nCoV-19 corona virus vaccine (Oxford-AstraZeneca/Covishield): report of two cases. Dermatol Ther. 2021;34(5):e15085. doi:10.1111/dth.15085
   PubMed Web of Science ®Google Scholar
• Sotiriou E, Tsentemeidou A, Bakirtzi K, Lallas A, Ioannides D, Vakirlis E. Psoriasis exacerbation after Covid-19 vaccination: report of 14 cases from a single center. J Eur Acad Dermatol Venereol. 2021;35(12). doi:10.1111/jdv.17582
   Web of Science ®Google Scholar
• Gunes AT, Fetil E, Akarsu S, Ozbagcivan O, Babayeva L. Possible triggering effect of influenza vaccination on psoriasis. J Immunol Res. 2015;2015:258430. doi:10.1155/2015/258430
   PubMed Web of Science ®Google Scholar
• Yoneyama S, Kamiya K, Kishimoto M, Komine M, Ohtsuki M. Generalized exacerbation of psoriasis vulgaris induced by pneumococcal polysaccharide vaccine. J Dermatol. 2019;46(11):e442–e43. doi:10.1111/1346-8138.15007
   PubMed Web of Science ®Google Scholar
• Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci. 2019;20(18):4347. doi:10.3390/ijms20184347
   PubMed Web of Science ®Google Scholar
• Shi CR, Nambudiri VE. Widespread psoriasis flare following influenza vaccination. Vaccine. 2017;35(36):4785–4786. doi:10.1016/j.vaccine.2017.06.067
   PubMed Web of Science ®Google Scholar
• Tian Z, Huang Y, Yue T, et al. A Chinese cross-sectional study on depression and anxiety symptoms in patients with psoriasis vulgaris. Psychol Health Med. 2019;24(3):269–280. doi:10.1080/13548506.2018.1529323
   PubMed Web of Science ®Google Scholar